SCHEMBL5124496

SCHEMBL5124496

Cc1noc(-c2ccc(-c3cc(NC(=O)c4ccsc4)ccc3C)cc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.57
KMT2A Q03164 4/20 0.48
HPGD P15428 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KCNK3 O14649 1/20 0.42
KCNK9 Q9NPC2 1/20 0.42
LCK P06239 1/20 0.42
CSF1R P07333 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5113564 0.82 MAPK14 (0.61) MAPK14KMT2ALCKCSF1R
SCHEMBL5116783 0.82 MAPK14 (0.58) MAPK14KMT2AHPGDNPC1RAB9A
SCHEMBL3525920 0.79 MAPK14 (0.54) MAPK14KMT2AHPGDNPC1RAB9A
SCHEMBL5110981 0.78 HTR1D (0.54) MAPK14KMT2AHPGDRAB9AMEN1
SCHEMBL4820863 0.78 MAPK14 (0.74) MAPK14KMT2ANPC1RAB9AKCNK3
SCHEMBL4818830 0.76 MAPK14 (0.72) MAPK14KMT2AKCNK3KCNK9HSPB1
SCHEMBL4812867 0.76 MAPK14 (0.71) MAPK14KMT2AHSPB1
SCHEMBL5384693 0.75 KMT2A (0.67) MAPK14KMT2AHPGDNPC1RAB9A
SCHEMBL5124579 0.74 MAPK14 (0.63) MAPK14KMT2ALCKCSF1R
SCHEMBL4820018 0.73 MAPK14 (0.67) MAPK14KMT2AHPGDHSPB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-7425555-B2 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2008-09-16 US disclosed
US-20060089393-A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors GLAXOSMITHKLINE LLC 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089393-A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors MAPK1, MAPK7, MAP3K1 MAPK14 8/4885KMT2A 3587/4885HPGD 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.